Mehrdad Asghari Estiar
Overview
Explore the profile of Mehrdad Asghari Estiar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
278
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Estiar M, Mehdipour P
Cancer Biol Med
. 2018 Sep;
15(3):210-227.
PMID: 30197789
The gene is mutated in the syndrome, ataxia-telangiectasia (AT), which is characterized by predisposition to cancer. Patients with AT have an elevated risk of breast and brain tumors Carrying mutations...
2.
Mousavi A, Hashemzadeh S, Bahrami T, Estiar M, Feizi M, Pouladi N, et al.
Clin Lab
. 2018 May;
64(5):871-876.
PMID: 29739049
Background: Stromal cell-derived factor-1 (also called CXCL12) and its receptor, CXCR4, have a key role in the pathogenesis and tumorigenesis of various cancers. The aims of the current study were...
3.
Nemati M, Ajami N, Estiar M, Rezapour S, Ravanbakhsh Gavgani R, Hashemzadeh S, et al.
Adv Clin Exp Med
. 2018 Mar;
27(3):305-311.
PMID: 29558042
Background: To date, 4 classes of histone deacetylases (HDACs) have been identified in humans. Class I HDACs are zinc-dependent and NAD+-independent enzymes, and include 4 isoforms closely related to yeast...
4.
Kazemi N, Estiar M, Fazilaty H, Sakhinia E
Gene
. 2018 Jan;
647:93-100.
PMID: 29289611
Non-syndromic stuttering is a neurodevelopmental disorder characterized by disruptions in normal flow of speech in the form of repetition, prolongation and involuntary halts. Previously, mutations with more severe effects on...
5.
Estiar M, Javan F, Zekri A, Mehrazin M, Mehdipour P
Cancer Biomark
. 2017 Apr;
19(3):341-351.
PMID: 28453467
Background: Astrocytoma and meningioma are the most common primary brain tumors. MYCN as a member of MYC proto-oncogenes has recently appeared as an attractive therapeutic target. Functions of MYCN are...
6.
Estiar M, Zare A, Esmaeili R, Farahmand L, Fazilaty H, Jafari D, et al.
Future Oncol
. 2017 Mar;
13(11):961-969.
PMID: 28326836
Aim: The expression level of NDRG3 gene is investigated among breast cancer (BC) patients. Methods: Real-time quantitative PCR was performed. Results: NDRG3 was downregulated in BC patients particularly in advanced...
7.
Sharif S, Hashemzadeh S, Ardehaie R, Eftekharsadat A, Ghojazadeh M, Mehrtash A, et al.
Oncol Lett
. 2017 Jan;
12(6):5335-5343.
PMID: 28105243
Colorectal cancer (CRC) is one of the most common malignancies, and the third leading cause of cancer mortality worldwide. Timely detection of CRC in patients with earlier stages provides the...
8.
Sharifi N, Salmaninejad A, Ferdosi S, Bajestani A, Khaleghiyan M, Estiar M, et al.
Oncol Lett
. 2017 Jan;
12(6):4651-4658.
PMID: 28105172
Prostate cancer (PCa) is one of the most widespread malignancies in the world. The role of the human epidermal growth factor receptor 2 (HER2) in the pathogenesis and progression of...
9.
Khabbazi A, Zolrahim F, Estiar M, Sakhinia E, Kolahi S
Iran J Public Health
. 2016 Dec;
45(10):1383-1385.
PMID: 27957452
No abstract available.
10.
Estiar M, Esmaeili R, Zare A, Farahmand L, Fazilaty H, Zekri A, et al.
Clin Exp Med
. 2016 Dec;
17(4):547-553.
PMID: 27909883
Carcinoembryonic antigen (CEA) family members play important roles in malignancies and are introduced as biomarkers in different types of cancers. Among them CEACAM19 (CEAL1) gene, a new member of the...